Phosducin-like 3 as a Biomarker in Glioma
Author Information
Author(s): Xue Jihao, Yin Qijia, Wang Ming, Li Yanling
Primary Institution: Southwest Medical University
Hypothesis
Is PDCL3 a potential prognostic biomarker for glioma?
Conclusion
The study highlights the need for rigorous validation of predictive models in glioma research.
Supporting Evidence
- PDCL3 was identified as a potential prognostic biomarker for glioma.
- The authors constructed a nomogram based on Cox regression analysis.
- Statistical tests indicated that several variables did not meet the proportional hazards assumption.
Takeaway
This article talks about a study that found a new marker for glioma, but it also warns that researchers need to be careful when using certain statistical methods.
Methodology
The authors performed univariate and multivariate Cox regression analyses and tested the proportional hazards assumption.
Potential Biases
There is a risk of inaccuracies and biases if the proportional hazards assumption is violated.
Limitations
The study emphasizes the importance of adhering to the proportional hazards assumption in Cox regression models.
Statistical Information
P-Value
p > 0.05
Statistical Significance
p > 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website